Ash Jayagopal

Opus Genetics, a patient-focused gene therapy company developing treatments for orphan inherited retinal diseases, has announced a key appointment to its founding executive team. Ash Jayagopal has joined the company as Chief Scientific Officer. Ash Jayagopal Jayagopal, BE’03, MS’05, PhD’08, is a biomedical engineering graduate who also served as an… Read More